Zymeworks BC Target Price

Where could ZYME trade next? Consensus target price: $39.

Get informed when a big investor buys or sells

+ Follow

Share Price

$25.73

Average Target Price

$38.88

51.1% upside

8 analysts in the last 4 months

High: $51 | Low: $28

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-08-07	Truist FinancialGregory Renza	$32	24.4% upside
2026-08-07	Stifel Nicolaus	$46	78.8% upside
2026-08-07	Wells Fargo	$40	55.5% upside
2026-08-05	H.C. Wainwright	$51	98.2% upside
2026-07-07	Truist Financial	$31	20.5% upside
2026-06-30	Wells Fargo	$37	43.8% upside
2026-06-09	Truist FinancialGregory Renza	$28	8.8% upside
2026-06-03	H.C. WainwrightAndrew Berens	$46	78.8% upside
2026-03-09	Evercore ISI	$48	86.6% upside
2025-12-17	Truist FinancialAsthika Goonewardene	$40	55.5% upside
2025-12-12	Wells Fargo	$33	28.3% upside
2025-12-03	JMP Securities	$32	24.4% upside
2025-11-19	Wells FargoEva Verdejo	$25	2.8% downside
2025-11-19	Stifel NicolausStephen Willey	$40	55.5% upside
2025-11-17	Leerink PartnersAndrew Berens	$37	43.8% upside
2025-10-14	H.C. WainwrightRobert Burns	$26	1% upside
2024-11-21	Leerink PartnersAndrew Berens	$26	1% upside
2024-11-01	Wells FargoDerek Archila	$12	53.4% downside
2024-10-28	Stifel NicolausStephen Willey	$28	8.8% upside
2024-09-25	H.C. WainwrightRobert Burns	$12	53.4% downside
2024-09-18	H.C. WainwrightAndrew Berens	$10	61.1% downside
2024-09-10	Stifel NicolausStephen Willey	$21	18.4% downside
2022-12-19	JefferiesAkash Tewari	$11	57.2% downside
2022-11-01	H.C. WainwrightRobert Burns	$8	68.9% downside
2021-09-20	H.C. WainwrightRobert Burns	$44	71% upside

Zymeworks BC (ZYME) FAQ

As of the most recent data, ZYME shows a target price of $39. Scroll down for historical charts and peer comparison views.

If Zymeworks BC moved to the average analyst target of $39, shares would be roughly 51.1% higher than $25.73. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of Zymeworks BC's earnings trajectory.

Besides this target price page, Stockcircle has Zymeworks BC's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $39) with ownership activity and broader fundamentals.

Zymeworks BC's target price is $39; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.